drugset / Trial / NCT04446052

Phase III rhu_GM-CSF + 3 Induction Regimens in Adults With Acute Non-Lymphocytic Leukemia

NCT04446052

Phase 3 Completed 362 enrolled Eastern Cooperative Oncology Group
RandomizedParallel-groupTriple-blindTreatment

Summary

Phase III Study of Priming with Granulocyte-Macrophage Colony Stimulating Factor (rhu-GM-CSF) and ofThree Induction Regimens in Adult Patients (Over 55) with Acute Non-Lymphocytic Leukemia

Timeline

Start
1993-05-21
Primary completion
2002-07-10
Completion
2002-07-10

Drugs

EvaluationDrugModalityDoseRoute
Comparator sargramostim Protein / enzyme biologic